We are live on ! Find out more
MORF

Morphic Holding, Inc. Common Stock

Delisted

MORF was delisted on the 15th of August, 2024.

109 hedge funds and large institutions have $1.6B invested in Morphic Holding, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 35 increasing their positions, 29 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

640% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 5

127% more capital invested

Capital invested by funds: $703M → $1.6B (+$896M)

100% more funds holding in top 10

Funds holding in top 10: 36 (+3)

42% more funds holding

Funds holding: 77109 (+32)

21% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 29

Holders
109
Holders Change
+32
Holders Change %
+41.56%
% of All Funds
1.91%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.11%
New
37
Increased
35
Reduced
29
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$341M +$33.2M +723,667 +16%
EC
2
EcoR1 Capital
California
$190M +$7.32M +159,431 +6%
NHAS
3
Novo Holdings A/S
Denmark
$167M
OFM
4
Omega Fund Management
Massachusetts
$144M -$29.8M -649,293 -22%
AG
5
Artal Group
Luxembourg
$115M +$7.69M +167,500 +10%
BlackRock
6
BlackRock
New York
$73.1M +$4.39M +95,583 +9%
Vanguard Group
7
Vanguard Group
Pennsylvania
$60.1M +$11.3M +247,130 +35%
PA
8
Perceptive Advisors
New York
$59.4M +$20.7M +451,140 +93%
MWNA
9
Marshall Wace North America
New York
$36.9M +$20.6M +447,822 +330%
JG
10
Jefferies Group
New York
$31M +$22.5M +490,432 New
Point72 Asset Management
11
Point72 Asset Management
Connecticut
$26.1M +$2.44M +53,200 +15%
Ensign Peak Advisors
12
Ensign Peak Advisors
Utah
$25M +$14.4M +314,764 +392%
Alkeon Capital Management
13
Alkeon Capital Management
New York
$24.8M +$11.1M +242,000 +161%
T. Rowe Price Associates
14
T. Rowe Price Associates
Maryland
$23.4M +$17M +370,507 New
Marshall Wace
15
Marshall Wace
United Kingdom
$22.5M +$16.3M +355,678 New
CAM
16
Cormorant Asset Management
Massachusetts
$22.1M +$6.89M +150,000 +75%
Federated Hermes
17
Federated Hermes
Pennsylvania
$19M +$13.8M +299,766 +108,219%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$15.6M +$2.97M +64,699 +35%
State Street
19
State Street
Massachusetts
$15.3M -$87.4K -1,905 -0.8%
FT
20
Fiduciary Trust
Massachusetts
$13.6M
DCM
21
Driehaus Capital Management
Illinois
$13M +$7.7M +167,737 +447%
AAA
22
Affinity Asset Advisors
New York
$12.3M +$5.85M +127,500 +189%
DCM
23
DAFNA Capital Management
California
$11.5M +$5.51M +120,000 +195%
Northern Trust
24
Northern Trust
Illinois
$11.3M -$125K -2,714 -2%
PCH
25
Polar Capital Holdings
United Kingdom
$9.49M +$6.89M +150,000 New

MORF Hedge Fund Activity: Q1 2021 in Review

109 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Morphic Holding, Inc. Common Stock (MORF) for Q1 2021, worth a combined $1.6B — up 127% from $703M a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new MORF positions and 5 closed out — a net gain of 32 holders — while 35 added to existing stakes and 29 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $33.2M. The largest seller was Omega Fund Management, cutting an estimated $29.8M.

  • 109 institutional investors held Morphic Holding, Inc. Common Stock (MORF) as of Q1 2021, up from 77 in Q4 2020.
  • Funds reported $1.6B of Morphic Holding, Inc. Common Stock stock for Q1 2021, up 127% quarter-over-quarter.
  • 37 funds opened new Morphic Holding, Inc. Common Stock positions in Q1 2021 and 5 closed out, a net change of +32 holders.
  • The largest Morphic Holding, Inc. Common Stock buyer in Q1 2021 was Fidelity Investments, an estimated $33.2M added.
  • The largest Morphic Holding, Inc. Common Stock seller in Q1 2021 was Omega Fund Management, an estimated $29.8M sold.

Based on aggregated 13F filings for Q1 2021.